Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
18.66
-0.02 (-0.11%)
At close: Oct 22, 2026, 4:00 PM EDT
18.64
-0.02 (-0.11%)
Pre-market: Oct 23, 2026, 8:22 AM EDT
Denali Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +87.57% | Aug 25, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $29 | Buy | Maintains | $29 | +55.41% | Aug 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $42 | Buy | Maintains | $42 | +125.08% | Aug 7, 2026 |
| UBS | UBS | Buy Reiterates $25 → $34 | Buy | Reiterates | $25 → $34 | +82.21% | Aug 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $36 → $40 | Buy | Reiterates | $36 → $40 | +114.36% | Aug 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $41 | Buy | Reiterates | $41 | +119.72% | Aug 7, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $31 → $34 | Buy | Maintains | $31 → $34 | +82.21% | Aug 7, 2026 |
| BTIG | BTIG | Buy Maintains $39 | Buy | Maintains | $39 | +109.00% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.